|
|
Anticort
is believed to lower levels of cortisol in the body. Cortisol,
which is a naturally-occurring immuno-suppressive steroid,
is believed to be elevated in people with HIV disease.
|
|
Objective
|
To
determine whether Anticort is safe and effective in lowering
levels of cortisol, which acts as an immuno-supressing
agent. |
|
|
Four (4) dose groups of 12-weeks each (an in-patient
study). Each
group must be enrolled sequentially.
(For
more information on study enrollment, please contact
Corie Castro at the phone number or email address below.)
|
|
Inclusion
Criteria
|
- HIV-positive
male or female 18 y.o. or older
- On
stable retroviral therapy for at least 8 weeks prior
to trial entry
- T-cell
count greater than 200
- If
female, not pregnant and willing to use contraceptives
for the duration of the study
|
|
Status
__
|
Enrolling
--
|
For
more information about participating in this study
in the Los Angeles area, please call 310/358.2429
or e-mail Corie Castro at ccastro@aidsresearch.org
|
|
We
encourage participation by women and people of color.
This
ad was reviewed and approved by the AIDS Research Alliance
Institutional Review Board in January, 2001.
|
